American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Open accessThe DOI matches its Crossref record; 166 of the 171 references it cites were found in a registry or an index.
Abstract
Does inpatient management of hyperglycemia represent a safety concern? 5. What systems need to be in place to achieve these recommendations?6.Is treatment of inpatient hyperglycemia cost-effective?7. What are the optimal strategies for transition to outpatient care? 8. What are areas for future research? QUESTION 1: DOES IMPROVING GLYCEMIC CONTROL IMPROVE CLINICAL OUTCOMES FOR INPATIENTS WITHHYPERGLYCEMIA? -Hyperglycemia in hospitalized patients, irrespective of its cause, is unequivocally associated with adverse outcomes (5,6,18 -25).Hyperglycemia occurs in patients with known or undiagnosed diabetes, or it occurs during acute illness in those with previously normal glucose tolerance (termed "stress hyperglycemia") (8,26).Intervention directed at reducing blood glucose (BG) levels has resulted in improved outcomes in some, but not all, studies (5,18 -25).Several recent clinical trials in critically ill patients have reported no reduction in mortality from intensive treatment targeting near-euglycemia versus conventional management targeting BG Ͻ180 mg/dl (Ͻ10.0 mmol/l).Of considerable concern are reports of harm, with higher rates of severe hypoglycemia and even increased mortality (14) resulting from intensive glycemic control (12)(13)(14)16,27,28).This variability in results may be attributable to several factors, including differences in intravenous (IV) insulin treatment protocols and their implementation, glycemic targets, patient populations, methods for glucose monitoring, and insulin adjustment (12,29).The following section focuses primarily on results of recent studies with an RCT design that investigated patient outcomes with protocols targeting nearnormalization of BG levels.Readers are referred to a previous ACE position statement (9), an ACE/ADA consensus statement (11), and a technical review (8) for details related to earlier studies supporting inpatient glycemic management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Those without preexisting DM or stress hyperglycemia have a higher incidence of more postheart surgery complications.91,100–103”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [103]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Glucose targets >180 mg/dL or <110 mg/dL are no longer recommended in ICU patients.”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“and the BG targets used in this study were lower than glycemic targets recently recommended by the AACE and ADA inpatient glycemic control task force.25”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“Many guidelines that apply to hospitalized adults with hyperglycemia can probably be extrapolated to older adults130, 131.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 4×
“Nevertheless, recent attempts to achieve tight glycemic control either have not reduced or have actually increased mortality in multicenter trials and clearly led to higher rates of hypoglycemia (13,14,16).”
BackgroundInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921 · cited 5×
“The higher rates of severe hypoglycemia associated with intensive insulin therapy (12–14,16,27,28) raise the possibility that serious adverse events in the subgroup of patients experiencing hypoglycemia offset, at least in part, any benefit derived from strict glycemic control in the much larger subgroup of patients w…”
BackgroundInfluentialHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationCapes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Bates, D. W. (1998) · JAMA · doi:10.1001/jama.280.15.1311 · Cited by 2,107
The Incidence and Severity of Adverse Events Affecting Patients after Discharge from the Hospital
Forster, A. J., Murff, H. J., Peterson, J. F., Gandhi, T. K., & Bates, D. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00007 · Cited by 1,886 · cited 1×
“Medication errors and adverse drug events have been linked to poor communication of instructions to the patient at the time of discharge (156,157).”
Background
Research works printed but not linked: 5
- 28. Devos P, Preiser JC, Me ´lot C, et al. Im- pact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the GluControl study (Abstract). Intensive Care Med 2007;33:S189
- 87. Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13(Suppl. 1):1-68
- 93. DiNardo M, Donihi AC, DeVita M, et al. A nurse directed protocol for recogni- tion and treatment of hypoglycemia in hospitalized patients. Pract Diabetol 2005;22:37-40
- 97. Donihi AC, Rea RS, Mihalko MA, et al. Comparison of different methods of transitioning MICU patients from intra- venous to subcutaneous insulin (Ab- stract). Diabetes 2007;57:A542
- 117. Reider J, Lin H, Dinardo M, et al. Efficacy of a guideline for treatment of corticoste- roid related hyperglycemia in the hospi- tal (Abstract). Diabetes 2008;57:A574 120.
Cited by
Items 601–700 of 1,001
An unexpectedly high prevalence of undiagnosed diabetes in patients awaiting lung transplantation
Hackman, K. L., Snell, G. I., & Bach, L. A. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.10.010 · Cited by 13
Rousseau, M.-P., Beauchesne, M.-F., Naud, A.-S., Leblond, J., Cossette, B., Lanthier, L., Grondin, F., & Bernier, F. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.01.013 · Cited by 13
Hyperglycemia in-hospital management
Prieto, L. M. (2011) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810397083 · Cited by 13
“Hypoglycemia is defined as a blood glucose level lower than 70 mg/dl (< 4 mmol/l) with the presence of symptoms, and severe hypoglycemia is defined as a level lower than 40 mg/dl (2.2 mmol/l) [American Diabetes Association, 2011; Moghissi et al. 2009].”
BackgroundInfluentialIntensive Control of Diabetes in the Hospital: Why, How, and What is in the Future?
Hsia, E., & Draznin, B. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500637 · Cited by 13
MacMaster, H. W., Gonzalez, S., Maruoka, A., San Luis, C., Stannard, D., Rushakoff, J. A., & Rushakoff, R. J. (2019) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2018.08.006 · Cited by 12
Li, X., Meng, J., Dai, X., Liu, P., Wu, Y., Wang, S., Yin, H., & Gao, S. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01471-x · Cited by 12
“The presence of diabetes complicates the management of critically ill patients, as stress-induced hyperglycemia is often observed in these patients, further worsening their prognosis [3, 4].”
Ali, Z., Shah, M. A., Mir, S., Hassan, N., & Masoodi, S. (2020) · Anesthesia Essays and Researches · doi:10.4103/aer.aer_21_20 · Cited by 12
Kulasa, K. M., Serences, B., Nies, M., El-Kareh, R. E., Kurashige, K., & Box, K. W. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820966616 · Cited by 12
“We created three periods of the study: (1) the pre-eMAR integration period (August 2013-September 2017); (2) the eMAR integration period (October 2017-December 2017); and (3) the post-eMAR integration period (January 2018May 2019).”
MethodBundles do combate à fraqueza adquirida na unidade de terapia intensiva
Machado, J., Castro, M. G., Giacomassi, I. W. S., Giorelli, G., Isola, A., Silva, J. M., Dib, R., & Toledo, D. O. (2021) · Braspen Journal · doi:10.37111/braspenj.2021.36.2.01 · Cited by 13
Peterson, D. A., Sloan, M. A., Whitlow, P. L., Williams, D. O., Krumholz, H. M., Morrison, D. A., Ornato, J. P., Pearle, D. L., Green, L. A., Hochman, J. S., et al. (2009) · Cited by 12
Helmle, K. E., Edwards, A. L., Kushniruk, A. W., & Borycki, E. M. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.059 · Cited by 12
Diabetes im Krankenhaus: Perioperative Einstellung der Patienten
Gallwitz, B. (2019) · Deutsches Ärzteblatt · doi:10.3238/persdia.2019.05.17.01 · Cited by 12
Kattan, W., & Abduljawad, A. A. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.05.031 · Cited by 12
Mbanya, J. C., Lamptey, R., Uloko, A. E., Ankotché, A., Moleele, G., Mohamed, G. A., Ramracheya, I., Ramaiya, K. L., Ndiweni, M., Mbaye, M. N., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00958-z · Cited by 12
“It has been demonstrated that postprandial hyperglycaemia confers an increased risk of diabetes complications and poor outcomes [57, 58].”
BackgroundArgyropoulos, T., Korakas, E., Gikas, A., Kountouri, A., Kostaridou, S., Raptis, A. E., & Lambadiari, V. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.670976 · Cited by 12
“Specifically, according to the latest American Diabetes Association and American Association of Clinical Endocrinologists consensus, stress hyperglycemia is defined as any transient inpatient plasma glucose levels > 140 mg/dl (fasting plasma glucose of >126 mg/dl or random plasma glucose> 200mg/dl) without evidence of…”
BackgroundGlycemic control in critically ill: A moving target
Todi, S. K. (2014) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.130574 · Cited by 12
Guidelines for Care of the Hospitalized Patient with Hyperglycemia and Diabetes
Crawford, K. (2012) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2012.11.001 · Cited by 12
Prevalence of diabetes in patients admitted to a cancer hospital
Morganstein, D. L., Tan, S., Gore, M. E., & Feher, M. D. (2012) · The British Journal of Diabetes · doi:10.1177/1474651412459091 · Cited by 12
Essentials of Sepsis Management
Green, J. M. (2014) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.10.006 · Cited by 12
Pan, J., Zou, J., Bao, Y., Zhang, L., Han, J., Tang, J., Ma, X., Li, Q., & Jia, W. (2012) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3182464ba4 · Cited by 12
Hulst, A. H., Visscher, M. J., Godfried, M. B., Thiel, B., Gerritse, B. M., Scohy, T. V., Bouwman, R. A., Willemsen, M. G. A., Hollmann, M. W., DeVries, J. H., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022189 · Cited by 12
Cardona, S., TSEGKA, K. G., Pasquel, F. J., Fayfman, M., Peng, L., Jacobs, S., Vellanki, P., Halkos, M. E., Guyton, R. A., Thourani, V. H., et al. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000703 · Cited by 12
“23 24 44 47 The increased risk of iatrogenic hypoglycemia with insulin therapy has triggered the search of alternative approaches and treatment regimens.”
Self-citationLiu, Y., Shi, Y., Zhu, J., Chen, X., Yang, R., Shu, B., Zhou, Z., Liu, J., Wu, R.-Q., & Xie, J. (2020) · Advances in Wound Care · doi:10.1089/wound.2018.0903 · Cited by 12
Challenges and Strategies for Inpatient Diabetes Management in Older Adults
Gosmanov, A. R., Mendez, C. E., & Umpierrez, G. E. (2020) · Diabetes Spectrum · doi:10.2337/ds20-0008 · Cited by 13
Self-citationExamining Factors That Impact Inpatient Management of Diabetes and the Role of Insulin Pen Devices
Smallwood, C., Lamarche, D., & Chevrier, A. S. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.07.001 · Cited by 12
Ang, L., Lin, Y. K., Schroeder, L. F., Huang, Y., DeGeorge, C. A., Arnold, P., Akanbi, F., Knotts, S., DuBois, E., Desbrough, N., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241241005 · Cited by 11
Volpi, S., Rajah, T., & Ali, J. M. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-24-1112 · Cited by 11
“Clinical guidelines including The Joint British Diabetes Societies, recommend the use of IV CII for the management of hyperglycaemia in critically ill patients even those without a history of diabetes (12,73-75).”
Bajwa, S. J., & Singh, A. (2013) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/0970-9185.111749 · Cited by 11
Use of Personal Health Records to Support Diabetes Self-management: An Integrative Review
Fisher-Grace, K., Turk, M. T., Anthony, M. K., & Chia, L. (2020) · CIN Computers Informatics Nursing · doi:10.1097/cin.0000000000000682 · Cited by 11
“This finding is important because persons with diabetes are more likely to be admitted to a hospital and to have a longer length of stay than those without diabetes.(30) The third gap revealed in this review is the lack of evidence of patient-specific factors influencing intention to use a PHR formanagement of T2DM.”
BackgroundBathari, A. C. R., Rahmawati, F., & Sari, I. P. (2021) · JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) · doi:10.22146/jmpf.57829 · Cited by 11
Wei, X., Min, Y., Yu, J.-C., Wang, Q., Wang, H., Li, S., & Su, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.757061 · Cited by 11
“Nevertheless, the recent guidelines pointed out the promising target levels of blood glucose was range from 140 to 180 mg/dl (46).”
BackgroundSamuel, H., Girma, B., Negash, M., & Aligaz, E. M. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000000464 · Cited by 11
Prevalence of dysglycaemic events among inpatients with diabetes mellitus: a Singaporean perspective
Ong, K. Y., Kwan, Y. H., Tay, H., Tan, D., & Chang, J. (2015) · Singapore Medical Journal · doi:10.11622/smedj.2015110 · Cited by 11
Wagstaff, A. E., & Cheung, N. W. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0444-2 · Cited by 11
Kemmerer, T., Bashura, H., Dintzis, J., Mathioudakis, N. N., & Golden, S. H. (2015) · AADE in Practice · doi:10.1177/2325160315598937 · Cited by 11
“in 2006, the American Association of clinical endocrinologists and the American Diabetes Association released a call to action outlining strategies to successfully implement hospital-wide glucose control efforts to improve care of hospitalized patients with diabetes and hyperglycemia.(5,6)”
BackgroundRamos, A., Zapata, L., Vera, P., Betbese, A. J., & Pérez, A. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.08.005 · Cited by 11
Interventions to improve perioperative neurologic outcomes
Vandiver, M. S., & Vacas, S. (2020) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000905 · Cited by 11
“Thus, glucose control in the 140–180mg/dl range is recommended for perioperative glycemic control [73].”
BackgroundDhatariya, K., & Umpierrez, G. E. (2022) · Diabetic Medicine · doi:10.1111/dme.14980 · Cited by 11
Self-citationApproach to the Hospitalized Patient with Severe Insulin Resistance
Larsen, J. L., & Goldner, W. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0255 · Cited by 11
Perioperative Care of Patients with Diabetes
Levesque, C. A. (2012) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2012.11.007 · Cited by 11
Management of diabetes by a healthcare team in a cardiology unit: a randomized controlled trial
Moraes, M. A., Rodrigues, J. A., Cremonesi, M., Polanczyk, C. A., & Schaan, B. D. (2013) · Clinics · doi:10.6061/clinics/2013(11)03 · Cited by 11
“6061/clinics/2013(11)03 CLINICAL SCIENCE”
BackgroundCheung, N. W., Cinnadaio, N., O’Neill, A., Koller, L. J., Pratt, H., Zingle, C., & Chipps, D. R. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.02.019 · Cited by 11
Nutritional support for critically ill patients: Does duration correlate with mortality?
Morais, Á. A. C., Faintuch, J., Caser, E. B., Costa, D. S., Pazolini, B. A., & Oliveira, A. C. (2011) · Journal of Critical Care · doi:10.1016/j.jcrc.2010.12.006 · Cited by 11
The Feasibility and Impact of Midnight Routine Blood Draws on Laboratory Orders and Processing Time
Sorita, A., Patterson, A., Landazuri, P., De-Lin, S., Fischer, C., Husk, G. A., & Sivaprasad, L. (2014) · American Journal of Clinical Pathology · doi:10.1309/ajcppl8kfh3kfhnv · Cited by 11
Perera, N., Harding, A., Constantino, M., Molyneaux, L. M., McGill, M. J., Chua, E., Twigg, S., Ross, G., & Yue, D. (2011) · Practical Diabetes · doi:10.1002/pdi.1612 · Cited by 11
Tides of Change: Improving Glucometrics in a Large Multihospital Health Care System
Mulla, C. M., Lieb, D. C., McFarland, R., & Aloi, J. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814563953 · Cited by 11
“The authors recommended a number of research questions for future studies to address, including what hospital systems are necessary to improve both inpatient glucose control as well as patient safety.(9) Inpatient glucose control involving an inpatient diabetes team, provider and staff education, and well-developed pr…”
BackgroundGangopadhyay, K. K., Bantwal, G., Talwalkar, P., Muruganathan, A., & Das, A. K. (2014) · PubMed · Cited by 11
Reduction of Insulin Related Preventable Severe Hypoglycemic Events in Hospitalized Children
Poppy, A., Retamal-Munoz, C., Cree‐Green, M., Wood, C., Davis, S., Clements, S. A., Majidi, S., Steck, A. K., Alonso, G. T., Chambers, C., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2015-1404 · Cited by 11
ST-Segment Elevation Myocardial Infarction
Kushner, F. G., & Bates, E. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0101-8.00010-2 · Cited by 11
Rodríguez-Calero, M. Á., Llodrá, E. B., Cuberos, M. C., Blanco‐Mavillard, I., & Axartell, M. A. P. (2018) · Enfermería Intensiva · doi:10.1016/j.enfi.2018.01.004 · Cited by 11
Diabetesmanagement im Krankenhaus (Update 2019)
Mader, J. K., Aberer, F., Brix, J. M., Föger, B., Hochfellner, D. A., Kietaibl, A.-T., Ludvik, B., Resl, M., Ress-Winkel, C., Stechemesser, L., et al. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-1447-z · Cited by 12
Valgardson, J. D., Merino, M., Redgrave, J., Hudson, J. I., & Hudson, M. (2015) · Endocrine Practice · doi:10.4158/ep14153.or · Cited by 11
Vellanki, P., Cardona, S., Galindo, R. J., Urrutia, M. A., Pasquel, F. J., Davis, G. M., Fayfman, M., Migdal, A., Peng, L., & Umpierrez, G. E. (2022) · Diabetes Care · doi:10.2337/dc21-1606 · Cited by 10
Self-citationThe rationale and the strategies to achieve perioperative glycaemic control
Stubbs, D. J., Levy, N., & Dhatariya, K. (2017) · BJA Education · doi:10.1093/bjaed/mkw071 · Cited by 10
Marino, E. C., Momesso, D., Toyoshima, M. T. K., de Almeida, M. F. O., Schaan, B. D., Negretto, L. A. F., Junior, A. C. S., Cukier, P., Genestreti, P., Feitosa, A. C. R., et al. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01585-z · Cited by 10
Safe and Effective Use of a Glycemic Control Protocol for Neonates in a Cardiac ICU*
Hebson, C. L., Chanani, N. K., Rigby, M. R., Wolf, M. J., Deshpande, S. R., Montegna, L. M., & Maher, K. (2013) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e31827200de · Cited by 10
Avanzini, F., Mafrici, A., Riva, E., Franzosi, M., Milani, V., Giudici, V., Marelli, G., Mariani, G., Piatti, P. M., & Roncaglioni, M. C. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.07.007 · Cited by 10
WENGER, N. K., Zidar, P., Jneid, H. M., Lincoff, A. M., Peterson, E. D., Philippides, G. J., Casey, D. E., Ettinger, S. M., Fesmire, F. M., Ganiats, T. G., et al. (2011) · Cited by 10
Yu, G., Ma, H., Lv, W., Zhou, P., & Liu, C. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13662 · Cited by 10
“The current professional guidelines still recommend the use of a wider range of blood glucose levels for severely ill adult patients [8,9].”
BackgroundHelmle, K. E., Dechant, A., & Edwards, A. L. (2018) · Clinical Diabetes · doi:10.2337/cd17-0078 · Cited by 10
“8–10 mmol/L (140–180 mg/dL) (4,6), and these narrower targets are endorsed by SHM (5) and AACE (4).”
BackgroundInfluentialInfluence of Hyperglycemia on Treatment Outcomes of Oral Cavity Squamous Cell Carcinoma
Lien, K., Padua, P. F., Tay, Z. Y., Kao, H., Hung, S., Huang, Y., Tsang, N., & Chang, K. (2020) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2020.01.018 · Cited by 10
Olveira, G., Abuín, J., López, R., Herránz, S., García‐Almeida, J. M., García-Malpartida, K., Ferrer, M., Cáncer, E., Pérez, L. M. L., Álvarez, J., et al. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0482 · Cited by 10
Kao, S. L., Chen, Y., Ning, Y., Tan, M. L. S., Salloway, M. K., Khoo, E. Y. H., Tai, E. S., & Tan, C. S. (2020) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-020-00107-2 · Cited by 10
Cook, C. A., Vakayil, V. R., Pribyl, K., Yerxa, D., Kriz, J., Case, A., Meisel, S. B., Ho, T., & Harmon, J. V. (2020) · Hospital Pharmacy · doi:10.1177/0018578720973891 · Cited by 10
Association of blood glucose level and prognosis of inpatients with coexistent diabetes and COVID-19
Duan, W., Li, L., Li, X., Zhu, M., Wu, L., Wu, W., Li, K., Liang, Y., Ding, R., You, W., et al. (2021) · Endocrine · doi:10.1007/s12020-021-02923-7 · Cited by 10
Design and Development of a Non-invasive Glucometer System
Ogunsanya, A. O., & Daramola, D. O. (2022) · West Indian Journal of Engineering · doi:10.47412/icpw8648 · Cited by 10
“In addition, a medical condition with low sugar levels (Hypoglycemia) is harmful and should be avoided (Umpierrez et al., 2012; Moghissi et al., 2019).”
BackgroundYang, W., Zhan, M., Li, Z. Y., Sun, X., & Zhang, K. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06634-y · Cited by 10
Thurber, K. M., Dierkhising, R. A., Reiland, S. A., Pearson, K. K., Smith, S. A., & O'Meara, J. G. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0103 · Cited by 10
“Patients were also treated with mealtime, basal, and correction-scale insulin concurrently per national inpatient hyperglycemia management guidelines 6,7 for at least 72 h and up to 7 days while hospitalized.”
Prevention, Diagnosis, and Management of Surgical Site Infections
de Mestral, C., & Nathens, A. B. (2013) · Critical Care Clinics · doi:10.1016/j.ccc.2013.06.009 · Cited by 10
Lleva, R. R., Thomas, P. G., Bozzo, J., Hendrickson, K. C., & Inzucchi, S. E. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814540871 · Cited by 10
Self-citationO'Sullivan, E., Duignan, J. A., O’Shea, P. M., Griffin, D. G., & Dinneen, S. F. (2013) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-013-0973-3 · Cited by 10
“We chose this definition, as this is the level above which treatment is recommended by the ADA [10] and the level at which the renal threshold for”
MethodEnsuring optimal insulin utilization in the hospital setting: Role of the pharmacist
Kelly, J. L. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100172 · Cited by 10
Chang, W. W., & Friedman, S. M. (2013) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2013.03.003 · Cited by 10
Hui, M. L., Kumar, A., & Adams, G. G. (2012) · Perioperative Medicine · doi:10.1186/2047-0525-1-7 · Cited by 10
Glycemic control in the infectious diseases ward; role of clinical pharmacist interventions
Farsaei, S., Karimzadeh, I., Elyasi, S., Hatamkhani, S., & Khalili, H. (2014) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.3357 · Cited by 10
Target Attainment Through Algorithm Design During Intravenous Insulin Infusion
Devi, R., Zohra, T., Howard, B. S., & Braithwaite, S. S. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0287 · Cited by 10
Relative Adrenal Insufficiency in Pediatric Septic Shock
Vila-Pérez, D., & Jordán-García, I. (2015) · Journal of Pediatric Intensive Care · doi:10.1055/s-0035-1559821 · Cited by 10
Bodnar, T. W., Iyengar, J. J., Patil, P. V., & Gianchandani, R. Y. (2016) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-016-0038-4 · Cited by 10
“Both hyperglycemia and hypoglycemia remain common problems among admitted patients with diabetes and have been associated with poor clinical outcomes [2, 3].”
BackgroundEvaluating an Order Set for Improvement of Quality Outcomes in Diabetic Ketoacidosis
Blair, A. M. J., Hamilton, B. K., & Spurlock, A. (2018) · Advanced Emergency Nursing Journal · doi:10.1097/tme.0000000000000178 · Cited by 10
“According to Moghissi et al. (2009), subcutaneous insulin is initiated 1–4 hr before discontinuing the intravenous insulin therapy for patients with DKA.”
BackgroundMethodInfluentialLuethi, N., Cioccari, L., Eastwood, G. M., Biesenbach, P., Morgan, R., Sprogis, S. K., Young, H., Peck, L., Chong, C. K., Moore, S., et al. (2019) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13354 · Cited by 10
Jude, E. B., Nixon, M., O’Leary, C., Myland, M., Gooch, N., Shaunik, A., & Lew, E. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0667-6 · Cited by 10
Computer-Based versus Paper-Based Insulin Infusion Algorithms in Diabetic Ketoacidosis
Younis, M., Pham, J., Asad, H., & Hamarshi, M. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666190712191932 · Cited by 10
Adherence to a Hypoglycemia Protocol in Hospitalized Patients: A Retrospective Analysis
Tracy, M. F., Manchester, C. S., Mathiason, M. A., Wood, J., & Moore, A. L. (2020) · Nursing Research · doi:10.1097/nnr.0000000000000478 · Cited by 10
Fan, E. Y., Crawford, A. S., Nguyen, T., Judelson, D. R., Learned, A., Chan, J., Schanzer, A. S., Simons, J. P., & Jones, D. W. (2022) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2022.02.052 · Cited by 10
Role of the Diabetes Educator in Inpatient Diabetes Management
American Association of Diabetes Educators (2018) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721718754817 · Cited by 10
How to manage type 2 diabetes in medical and surgical patients in the hospital
Umpierrez, G. E. (2011) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.78gr.11001 · Cited by 10
Self-citationPolderman, J. A. W., Houweling, P. L., Hollmann, M. W., DeVries, J. H., Preckel, B., & Hermanides, J. (2014) · BMC Anesthesiology · doi:10.1186/1471-2253-14-91 · Cited by 10
Complications associated with hyperglycemia in liver transplant patients
Builes-Montaño, C. E., Escobar, J. F. M., Londoño, C. A., Bayona, K. L. P., Restrepo, J. C., Restrepo, J. G., Toro, C. M. A., & Jaimes, F. A. (2014) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2014.08.004 · Cited by 10
“Hyperglycemia is defined as any glucose value > 140 mg/dl.(1) It occurs in 32 to 38% of all hospitalized patients, 41% of all the critically ill, 44% of patients with heart failure, and up to 80% of patients after cardiac surgery; between 30 and 80% of those individuals have no history of diabetes.”
BackgroundImpact of Diabetes Mellitus on Surgical Outcomes in Sports Medicine
Wolfson, T. S., Hamula, M., & Jazrawi, L. M. (2013) · The Physician and Sportsmedicine · doi:10.3810/psm.2013.11.2037 · Cited by 10
Heianza, Y., Suzuki, A., Fujihara, K., Tanaka, S., Kodama, S., Hanyu, O., & Sone, H. (2014) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2014-204054 · Cited by 10
Inzucchi, S. E., & Sherwin, R. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1604-7.00237-2 · Cited by 10
Self-citationRole of the Diabetes Educator in Inpatient Diabetes Management
(2017) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721716683813 · Cited by 10
“Diabetes-focused discharge planning should begin upon admission and continue throughout hospitalization to prepare for a smooth transition from hospital to outpatient care.(14,17,33) Diabetes case management adherence guidelines are available online from the Case Management Society of America.”
BackgroundContinuous Glucose Monitoring during Critical Care
Inzucchi, S. E., & Kosiborod, M. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181ff419e · Cited by 10
Self-citationPichardo-Lowden, A. R., & Haidet, P. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818817005 · Cited by 10
“While cause-effect association has not been clearly established, both conditions, regardless of an existing diagnosis of diabetes, seem to confer greater risk for poor clinical outcomes such as morbidity, mortality, use of resources, and hospital costs.(8,9) Many barriers hinder achieving adequate glucose control in t…”
BackgroundThangiah, G., Johar, H., Ismail, R., Reininghaus, U., Bärnighausen, T., Thurairajasingam, S., Reidpath, D. D., & Su, T. T. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610015 · Cited by 9
“Individuals with diabetes require comprehensive management that occurs both within and outside the health care system to prevent or delay complications, such as kidney failure, cardiovascular disease, amputation, or stroke [5,6].”
BackgroundGlycaemic control for patients with severe acute brain injury: Protocol for a systematic review
Fenger, A. W., Olsen, M. H., Fabritius, M. L., Riberholt, C. G., & Møller, K. (2022) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.14166 · Cited by 9
“Existing guidelines on glycaemic management are based on outcomes such as mortality and ICU admission time.(12,23) However, because many patients with acute brain injury survive with an unfa-”
BackgroundHe, Q., Tan, Z., Chen, D., Cai, S., & Zhou, L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1218127 · Cited by 9
Tratamiento de la hiperglucemia en el hospital. Impresiones y conocimientos del médico residente
Biagetti, B., Ciudin, A., Portela, M., Dalama, B., & Mesa, J. (2012) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2012.05.008 · Cited by 9
Yuan, S., & Shen, J. (2020) · Current Medical Science · doi:10.1007/s11596-020-2209-x · Cited by 9
Challenges in hyperglycemia management in critically ill patients with COVID-19
Kethireddy, R., Gandhi, D., Kichloo, A., & Patel, L. A. (2022) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v11.i4.219 · Cited by 9
Metadata
- Authors
- Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E.
- Affiliations
- University of California, Los Angeles (US)
- University of Pittsburgh (US)
- University of California San Diego (US)
- University of Missouri–Kansas City (US)
- University of Washington (US)
- Yale New Haven Hospital (US)
- Department of Medicine, Physiology and Biophysics, Division of Clinical and Molecular Endocrinology, Case Western Reserve University, Cleveland, Ohio;
- American Diabetes Association (US)
- Emory University (US)
- Corresponding author
- Moghissi, Etie S.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-06-01
- Volume
- 32
- Issue
- 6
- Pages
- 1119-1131
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2681039
- OpenAlex
- W2149347361
- Cited by
- 1,444
- References
- 171
- Citations by year
- 2026: 23 · 2025: 48 · 2024: 78 · 2023: 63 · 2022: 66 · 2021: 83 · 2020: 98 · 2019: 67 · 2018: 84 · 2017: 85 · 2016: 101 · 2015: 105 · 2014: 134 · 2013: 89 · 2012: 131
- FWCI
- 76.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- inpatient glycemic control, hyperglycemia, stress hyperglycemia, intensive insulin therapy, hypoglycemia, critically ill patients, hospitalized patients, transition to outpatient care, cost-effectiveness, glucose monitoring, clinical outcomes
- MeSH terms
- Blood Glucose, Consensus Statements as Topic, Diabetes Mellitus, Endocrinology, Humans, Hyperglycemia, Inpatients, Societies, Medical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.